Chronic obstructive pulmonary disease (COPD) patients with comorbid chronic cough appear to exhibit a more severe disease in terms of accompanying respiratory symptoms and healthcare utilization, lung function, and inflammation in blood, according to a study.
Use of azithromycin or subcutaneous immunoglobulins in combination with standard asthma medications in the management of patients with severe asthma (SA) and antibody deficiency improves SA control and reduces the frequency of exacerbations, as shown in a study.
Awareness of the risk factors for residual apnoeic–hypopnoeic events can improve the timely delivery of personalized care for patients with obstructive sleep apnoea (OSA), including the type of positive airway pressure (PAP) therapy, attention to comorbidities and choice of interface, a study has shown.
Airflow obstruction and lower lung volumes appear to increase the risk of endothelial dysfunction in middle-aged women, suggests a recent study. On the other hand, the evidence for such association in men is weaker.
Chronic kidney disease patients referred for right heart catheterization commonly have pulmonary hypertension (PH), with the combination of pre- and postcapillary PH subtypes associated with worst survival, a study reports.
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
At present, there are no definitive treatments for COVID-19. More than 300 clinical trials are ongoing in the search for a cure. Some of the treatments being tested were previously used, with varying levels of efficacy, in the treatment of severe acute respiratory syndrome (SARS) or Middle East respiratory syndrome (MERS).
Persons suffering from asthma should pay particular attention to SARS-CoV-2 precautionary measures such as social distancing, regular handwashing, and wearing of masks on top of keeping their asthma in control. This is because data collected so far paints a bleaker picture for asthmatics than the normal population should they catch COVID-19.